Sagility

Sagility Capital Expenditures

The Capital Expenditures (CapEx) of Sagility (SAGILITY.NS) as of Nov 3, 2026 is -1.92 B INR. In the previous year, Capital Expenditures (CapEx) was -1.24 B INR — a change of 54.46% (lower).

Capital Expenditures

-1.92 BINR

YoY

54.46%

Last updated:

Capital Expenditures (CapEx) of Sagility is 2026 -1.92 B INR. Capital Expenditures (CapEx) of Sagility was 2025 -1.24 B INR. It decreases by 54.46% lower compared to the previous year.

The Sagility Capital Expenditures history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Capital Expenditures
Date
Capital Expenditures
Jan 1, 2022
-105.81 M INR
Jan 1, 2023
-1.44 B INR
Jan 1, 2024
-1.83 B INR
Jan 1, 2025
-1.24 B INR
Jan 1, 2026
-1.92 B INR
The Sagility Capital Expenditures history
YEARCapital ExpendituresYoY
-1.92 BINR+54.46%
-1.24 BINR-31.90%
-1.83 BINR+27.18%
-1.44 BINR+1,257.92%
-105.81 MINR—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Sagility Stock analysis

What does Sagility do? Sagility India Ltd provides technology-enabled business solutions and services to clients in the United States healthcare industry. The company serves Payers, including United States health insurance companies that finance and reimburse health services, offering core benefits administration like claims management and enrolment. Sagility also caters to Providers, such as hospitals and physicians, delivering revenue cycle management services including medical coding and billing. Additionally, the firm supports pharmacy benefit managers managing prescription drugs for Members under health insurance plans. Sagility's primary clients are Payers, Providers, and pharmacy benefit managers within the U.S. healthcare sector. The company generates revenue through service contracts with these segments, focusing on operational efficiency for health insurance finance and healthcare delivery. Its services are tailored to meet the specific needs of each client type, from claims processing to medical billing and prescription drug management. The business model centers on delivering specialized technology-driven services to U.S. healthcare stakeholders. Sagility's revenue streams come from long-term contracts with Payers, Providers, and pharmacy benefit managers, emphasizing operational support in claims, benefits, and revenue cycle management. The company's focus on healthcare industry-specific solutions ensures consistent demand from its target client segments. Sagility is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Sagility stock

Capital Expenditures (CapEx) of Sagility is -1.92 B INR in 2026.

Capital Expenditures (CapEx) of Sagility changed from -1.24 B INR to -1.92 B INR, representing a 54.46% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Capital Expenditures (CapEx) Sagility since 2006 – with annual values, charts, and detailed analysis.

Capital expenditures represent investments in long-term assets such as property, equipment, and technology. CapEx is essential for maintaining and growing the business.

Capital Expenditures (CapEx)'s INR is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Capital Expenditures (CapEx)'s Sagility historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — Sagility

All Key Metrics — Sagility